LA
SLGC

Linden Advisors’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Linden Advisors’s Portfolio SLGC Stock Details SLGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-250,000
Closed -$3.07M – 693
2021
Q2 		$3.07M Buy
+250,000
New +$3.07M 0.02% 414

Other funds holding SLGC

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SM
SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Linden Advisors's SLGC Position: Q3 2021 in Review

Linden Advisors sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q3 2021, closing a stake of 250,000 shares — an estimated $3.07M sold.

Linden Advisors first reported a position in SLGC in Q2 2021 and held it in 1 quarter. The position peaked at $3.07M in Q2 2021. 86 funds tracked by Wall St. Rank hold SLGC as of Q3 2021.

  • Linden Advisors reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q3 2021 after selling out during the quarter.
  • Linden Advisors sold 250,000 SomaLogic, Inc. Class A Common Stock shares in Q3 2021, an estimated $3.07M.
  • Linden Advisors first reported a position in SomaLogic, Inc. Class A Common Stock in Q2 2021 and held it in 1 quarter.
  • Linden Advisors's SomaLogic, Inc. Class A Common Stock position peaked at $3.07M in Q2 2021.
  • 86 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q3 2021.

Based on Linden Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.